Crocs stock (NASDAQ:CROX) has just taken a severe hit – down 30% following disappointing guidance and the announcement that they are reducing orders for the remainder of the year. While the stock may appear inexpensive at 7x forward earnings, there is a strong likelihood that this is not the lowest point. The fundamentals are rapidly declining, and historical trends indicate that CROX typically suffers much more than the market during turbulent times. Separately, see – Amazon Stock To $100?
The Figures Tell the Truth
- Growth has hit a barrier: Crocs went from enjoying almost 20% revenue growth in recent years to a mere 3% in the last quarter. This isn’t just a slowdown – it’s akin to hitting the brakes.
- Profits are being crushed: Operating margins have plummeted from a robust average of 26% over four years to just 6% currently. This indicates a troubling trend.
- Earnings are declining: Last twelve months: $13.35 per share (down from $15.88 last year); Projected for 2025: $11.32
Yes, It Appears Inexpensive… But There’s a Catch
Trading at 7x forward adjusted earnings certainly catches the eye. However, herein lies the truth – sometimes stocks are cheap for specific reasons. The market might be anticipating further challenges instead of presenting a bargain. Also, take a look at – CROX Valuation Comparison.
What Could Go Awry From Here?
There are numerous factors that could prevent Crocs stock from bouncing back:
- The Growth Narrative Is Broken: The drop from 20% to 3% growth indicates that something fundamental has shifted.
- They’re Already Reducing Orders: If management is scaling back inventory, it shows their clear concern about demand.
- It’s Still Just Footwear: Crocs are not necessarily essential – when consumers start to cut back, quirky foam shoes aren’t the main focus.
- Fashion Is Unpredictable: What is popular today might not be tomorrow, and Crocs has always relied somewhat on trends.
- Economic Challenges: When the economy becomes unstable, this stock tends to face significant turbulence.
History Lesson: CROX Gets Hit Hard in Difficult Times
Here’s where it becomes intriguing (and alarming). Crocs doesn’t just decline during market stress – it gets thoroughly devastated:
2022 Inflation Crisis
- CROX was devastated: Down 73.9% (from $180.57 to $47.21)
- S&P 500: Down a more moderate 25.4%
- Recovery? Still waiting. The stock reached $159.68 in June 2024, but never returned to those 2021 highs. It is currently priced at $74.39.
2020 COVID-19 Crisis
- CROX again was hit hard: Down 75.2% (from $43.40 to $10.77)
- S&P 500: Down 33.9%
- Recovery? Actually rebounded quite swiftly, achieving pre-COVID levels by September 2020
- Check out – Buy or Sell CROX stock – for additional information.
But Wait – We Might Be Completely Incorrect
Here’s the reality about predicting market bottoms – surprises can occur. There are indeed reasons this could be the point where CROX begins its recovery:
- The Valuation Is Extremely Attractive: At 7x forward adjusted earnings, we are looking at a valuation that’s quite low. If the company can merely stabilize (not even experience substantial growth), that multiple could readily lead to significant increases.
- Management Might Be Anticipating Issues: Those order reductions and cautious guidance could turn out to be wise strategies. Perhaps they are being proactive instead of reactive, positioning themselves for more favorable comparisons next year.
- Brand Loyalty Is Still Strong: Despite all the financial turmoil, Crocs remains a well-known global brand with a dedicated customer base. The intrinsic demand for the product might simply be experiencing a temporary slowdown rather than a long-lasting drop.
- Economic Cycles Shift: If consumers are entering a phase where they begin to feel more positive about spending on discretionary items again, Crocs could disproportionately gain from that trend.
- Operational Leverage Works Both Ways: Just as margins declined on the way down, they could rebound swiftly if sales pick up. The fixed cost base means even slight revenue increases could yield substantial profit boosts.
If any combination of these elements takes place, the current price might look quite unreasonable in 2-3 years. Occasionally, the market overreacts in both directions, and we may be witnessing a significant downward overshoot right now.
So What’s the Situation?
The low valuation appears alluring, but the evidence indicates that the selling may not yet be complete. The fundamentals are worsening, not improving. Revenue growth has stagnated, margins are tightening, and management is currently reducing orders – none of this suggests a “bottom.”
Moreover, historical data reveals that when markets grow anxious, CROX tends to decline more severely and takes longer to recover than other stocks. Given the ongoing economic uncertainties, this pattern could very likely repeat.
The Honest Discussion
While some intrepid investors may wish to catch this falling knife at its current value, the clever money most likely bides its time. There’s a substantial possibility of witnessing another 30-40% drop from this point, potentially pushing the stock below $50. The 7x earnings multiple may appear enticing, but it could very well be the market’s way of signaling that earnings will diminish significantly. Sometimes inexpensive stocks become even cheaper before they improve.
In conclusion: The suffering is likely not finished yet. If you’re considering making a move, it might be wise to wait and observe if things genuinely start to turn around fundamentally before placing a bet on a rebound. Such situations prompt us to contemplate the risks involved in investing. There will always be a significant risk when investing in a single stock or just a few stocks. Consider the Trefis High Quality (HQ) Portfolio, which, with its collection of 30 stocks, has a proven record of comfortably outperforming the S&P 500 in the last 4-year timeframe. Why is that? As a collective, HQ Portfolio stocks have yielded better returns with reduced risk compared to the benchmark index; leading to a smoother ride, as illustrated in HQ Portfolio performance metrics.